Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) Revenue (2023 - 2025)

Coya Therapeutics (COYA) has disclosed Revenue for 3 consecutive years, with $4.0 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 202768.8% to $4.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.9 million through Dec 2025, up 123.57% year-over-year, with the annual reading at $7.9 million for FY2025, 123.57% up from the prior year.
  • Revenue hit $4.0 million in Q4 2025 for Coya Therapeutics, up from $3.6 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $6.0 million in Q4 2023 to a low of $1952.0 in Q4 2024.
  • Historically, Revenue has averaged $2.2 million across 3 years, with a median of $1.8 million in 2024.
  • Biggest five-year swings in Revenue: plummeted 99.97% in 2024 and later surged 202768.8% in 2025.
  • Year by year, Revenue stood at $6.0 million in 2023, then tumbled by 99.97% to $1952.0 in 2024, then soared by 202768.8% to $4.0 million in 2025.
  • Business Quant data shows Revenue for COYA at $4.0 million in Q4 2025, $3.6 million in Q3 2025, and $163616.0 in Q2 2025.